SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-006392
Filing Date
2022-02-23
Accepted
2022-02-23 16:15:32
Documents
13
Period of Report
2022-02-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K brhc10034332_8k.htm   iXBRL 8-K 26730
  Complete submission text file 0001140361-22-006392.txt   203238

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bngo-20220217.xsd EX-101.SCH 4385
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bngo-20220217_def.xml EX-101.DEF 17560
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bngo-20220217_lab.xml EX-101.LAB 27052
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bngo-20220217_pre.xml EX-101.PRE 19739
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10034332_8k_htm.xml XML 6226
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

IRS No.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 22663851
SIC: 3826 Laboratory Analytical Instruments